Alkalon is a Danish Specialty Pharma company focused on developing and commercializing medicated chewing gum formulations.
The company has its own portfolio of nicotine gums approved for smoking cessation and smoking reduction. Alkalon's products are commercialised through license and supply agreements with leading OTC companies who market and distribute under their own brands in all major European markets. The company has several pending registrations outside Europe and performs R&D work under co-development agreements with some of the world’s largest Pharma companies.
Alkalon’s in-house R&D activities take place in a well-equipped development laboratory with HPLC, masticating machine for dissolution testing, z-blade chewing gum mixer, rolling- and scoring equipment, coating pans, tabletting press, etc.
All non-core activities are outsourced.